Ligand profile
TNJ
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_02784 — DNA topoisomerase 4 subunit A
Identifiers
Database identifiers and provenance.
- Ligand ID
TNJ- PDB
6waa- UniProt (similar protein)
B5XU60- Target protein
- KP13_02784
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 77.3
- −1 ≤ LogP ≤ 5 1.92
- MW ≤ 500 Da 360.4
- LogP ≤ 5 1.92
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 5
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 77.3
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Cc1c2c(cc(c1N3C[C@H]4C[C@]4(C3)N)F)C(=C(C(=O)N2C5CC5)F)CNCc1c2c(cc(c1N3C[C@H]4C[C@]4(C3)N)F)C(=C(C(=O)N2C5CC5)F)CN
InChI=1S/C19H22F2N4O/c1-9-16-12(13(6-22)15(21)18(26)25(16)11-2-3-11)4-14(20)17(9)24-7-10-5-19(10,23)8-24/h4,10-11H,2-3,5-8,22-23H2,1H3/t10-,19-/m1/s1InChI=1S/C19H22F2N4O/c1-9-16-12(13(6-22)15(21)18(26)25(16)11-2-3-11)4-14(20)17(9)24-7-10-5-19(10,23)8-24/h4,10-11H,2-3,5-8,22-23H2,1H3/t10-,19-/m1/s1
LZLLPIGCIXMSRM-GIGQVBGESA-NLZLLPIGCIXMSRM-GIGQVBGESA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Source
- PDB
- Binding sites
- PF00521
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand TNJ →
- PDB RCSB structure 6waa →
- UniProt UniProt B5XU60 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “TNJ”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_02784.
PDB 22
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 15
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).